» Articles » PMID: 15734613

Spectrum and Prognostic Significance of Arrhythmias on Ambulatory Holter Electrocardiogram in Hypertrophic Cardiomyopathy

Overview
Date 2005 Mar 1
PMID 15734613
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The goal of this study was to assemble a profile and assess the significance of arrhythmias in a nontertiary-based hypertrophic cardiomyopathy (HCM) cohort.

Background: Hypertrophic cardiomyopathy is associated with arrhythmia-related consequences, particularly sudden death. Ventricular tachyarrhythmias on Holter electrocardiograms (ECG) have been reported as markers for sudden death in highly selected HCM populations.

Methods: We assessed the profile of ventricular and supraventricular ectopy and bradyarrhythmia on ambulatory 24-h Holter ECG and also related these findings to clinical outcome in 178 HCM patients.

Results: Of the 178 study patients, 157 (88%) had premature ventricular complexes (PVCs), including 21 (12%) with >/=500 PVCs, 74 (42%) had couplets, 67 (37%) had supraventricular tachycardia (SVT), and 56 (31%) had nonsustained ventricular tachycardia (NSVT). Mean number of PVCs was 330 +/- 763 (range 1 to 5,435) and increased with age (p < 0.01); NSVT was associated with greater left ventricular hypertrophy (p = 0.01) and severe symptoms (New York Heart Association functional classes III and IV) (p = 0.04); SVT occurred more commonly in patients with outflow obstruction (p = 0.02). Over a follow-up of 5.5 +/- 3.4 years, 11 (6%) patients died suddenly (annual mortality rate, 1.1%) including 5 patients with NSVT. For sudden death, NSVT on Holter ECG had negative and positive predictive values of 95% and 9%, and sensitivity and specificity of 45% and 69%, respectively.

Conclusions: In this nontertiary-based HCM cohort, ventricular and supraventricular tachyarrhythmias were particularly frequent and demonstrated a broad spectrum on ambulatory (Holter) ECG. Paradoxically, despite such a highly arrhythmogenic substrate, sudden death events proved to be relatively uncommon. Ventricular tachyarrhythmias had a low positive and relatively high negative predictive value for sudden death in this HCM population.

Citing Articles

Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.

Llamas-Esperon G, Berrios-Barcenas E, Cossio-Aranda J, Guerra-Lopez A, Magana-Serrano J, Iturralde-Torres P Arch Cardiol Mex. 2025; 94(Supl 4):1-75.

PMID: 39928711 PMC: 11824882. DOI: 10.24875/ACM.M25000098.


Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.

Verheyen N, Auer J, Bonaros N, Buchacher T, Dalos D, Grimm M Wien Klin Wochenschr. 2024; 136(Suppl 15):571-597.

PMID: 39352517 PMC: 11445290. DOI: 10.1007/s00508-024-02442-1.


The Unseen Side of Feline Hypertrophic Cardiomyopathy: Diagnostic and Prognostic Utility of Electrocardiography and Holter Monitoring.

Cofaru A, Murariu R, Popa T, Pestean C, Scurtu I Animals (Basel). 2024; 14(15).

PMID: 39123690 PMC: 11311041. DOI: 10.3390/ani14152165.


[Arrhythmias and Sudden Death Risk in Hypertrophic Cardiomyopathy].

Salinas-Arce J, Gonzales-Luna A, Cabrera-Saldana M, Mendoza-Novoa P, Alca-Clares R, Solorzano-Altamirano P Arch Peru Cardiol Cir Cardiovasc. 2024; 1(2):94-104.

PMID: 38572329 PMC: 10986354. DOI: 10.47487/apcyccv.v1i2.41.


Advancements in the diagnosis and management of premature ventricular contractions in pediatric patients.

Zhu W, Yuan H, Lv J Front Pediatr. 2024; 12:1373772.

PMID: 38571703 PMC: 10987820. DOI: 10.3389/fped.2024.1373772.